Elara Securities Bets on Pharma Revival: Zydus Life, Sun Pharma, Aurobindo Top Picks

• Elara Securities turns constructive on pharma stocks after two years of correction, citing reasonable valuations.
• Preferred picks include Zydus Life Sciences, Sun Pharma, Aurobindo Pharma, Gland Pharma, and Ajanta Pharma.
• Indian pharma companies, being net exporters, will benefit significantly from the sharply depreciated rupee.
• Diagnostics sector valuations have corrected, making it attractive; Dr Lal PathLabs is a preferred choice.
• Hospital sector remains in transition; investors advised to wait for clearer earnings stability.